The ALDH7A1 gene helps break down lysine, a protein building block, and supports healthy vitamin B6 balance in the brain. When both copies of this gene do not work properly, waste products can build up and interfere with vitamin B6, which may lead to pyridoxine dependent epilepsy, often starting with seizures in newborns or infants. Some children may also have developmental delays if treatment is delayed. This gene is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for making proteins, which are the working parts of cells. Others mainly help regulate when certain processes happen, where they take place, and how strongly they are turned on. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in LearnHub.
Overview
ALDH7A1Gene function
What if the gene works
The ALDH7A1 gene helps break down lysine, an amino acid from protein. Its protein also clears certain chemical byproducts, helping protect the brain and other tissues during everyday metabolism.
Risk
What if the gene does not work
People with pathogenic variants in the ALDH7A1 gene typically have pyridoxine-dependent epilepsy, with seizures often starting in newborns or infancy. Effects can range from milder to more severe, which may shape when symptoms appear and how development is affected.
Treatment
What does that mean for your treatment
Pathogenic variants in the ALDH7A1 gene usually make lifelong pyridoxine (vitamin B6) treatment a central part of care. Some people also use pyridoxal 5′-phosphate when needed. A lysine-restricted diet, often with arginine, can also be added to support seizure control and development.
Conditions associated with ALDH7A1
Gene function
What if the gene works
Your cells use the ALDH7A1 gene to handle a routine step in breaking down lysine, a building block of protein. Its protein also helps turn certain aldehydes, which are reactive chemical byproducts, into forms that are easier for the body to manage. Understanding how the ALDH7A1 gene works in the body helps explain its steady role in everyday cell chemistry.
It helps your cells complete an important step in breaking down lysine from food and normal protein turnover. Its enzyme changes alpha-aminoadipic semialdehyde (a short lived lysine byproduct) into alpha-aminoadipate so the pathway can keep moving.
This protein belongs to a family of enzymes that convert aldehydes (reactive chemical byproducts) into less reactive acids. By doing this, it supports steadier cell chemistry during normal metabolism.
In daily cell function, the ALDH7A1 gene helps limit a lysine byproduct that can tie up active vitamin B6, which many enzymes need to work. This supports normal enzyme activity in the brain and other tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALDH7A1 gene can make the enzyme unstable, folded into the wrong shape, or much less active, so certain cell chemicals build up and interfere with vitamin B6. Milder changes may leave some activity, while more severe variants can nearly stop it. This helps explain how ALDH7A1 gene variants affect protein function and why pyridoxine-dependent epilepsy may begin earlier or be more pronounced in some people.
How variants are linked to conditions
Pathogenic variants in both copies of the ALDH7A1 gene cause pyridoxine-dependent epilepsy, often called ALDH7A1-related pyridoxine-dependent epilepsy. This rare inherited condition usually begins with seizures in the newborn period or infancy, and some children also have developmental or learning difficulties. Finding disease-causing variants in the ALDH7A1 gene can confirm the diagnosis in a person with this pattern of symptoms.
A variant is not necessarily a diagnosis
Variants are a routine part of human biology and are widely found in the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In contrast, one well-characterized variant in a particular gene can sometimes be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALDH7A1, the main risk is inherited: a child is affected when they receive a disease-causing change in this gene from both parents. Risk is higher in families with a known ALDH7A1 change or when parents are blood relatives, while day-to-day lifestyle does not meaningfully change whether someone is born with this condition.
Inheritance of ALDH7A1 variants
ALDH7A1-related conditions are inherited in an autosomal recessive pattern. This means a child usually develops the condition only after inheriting two ALDH7A1 gene variants, one from each parent. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants. In families asking how ALDH7A1 variants are inherited, this pattern means the gene change can be passed down silently for generations before a child is affected.
What does my ALDH7A1 result mean for my family?
For families with an ALDH7A1-related condition, close relatives may also be carriers, even if they have never had symptoms. Brothers and sisters of an affected child may also be affected or be carriers, so the result can matter for siblings as well as future pregnancies. Extended family members, such as cousins, may also want to know there is a recessive condition in the family.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the ALDH7A1 gene, genetic testing uses a blood or saliva sample and reads the gene’s DNA code in a lab. ALDH7A1 genetic testing for pyridoxine-dependent epilepsy can identify variants linked to this condition and may help confirm the diagnosis when symptoms fit.
When should I consider getting a genetic test?
Consider ALDH7A1 testing if a baby or child has seizures that start very early, keep coming back, or improve with vitamin B6, especially if there are learning or movement problems. Testing can also help when this condition runs in the family or when parents are planning another pregnancy.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they explain depends on the condition and the kind of variant found. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes the most sense when considered alongside other parts of care. In other situations, a genetic result can give a definite answer. When it comes to medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment at the same dose, yet one may get the expected benefit while the other may notice less effect or more side effects. One reason is that inherited differences can change how the body breaks down, moves, or responds to a drug. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It looks at relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strong a drug’s effects are and how the body handles it. Understanding this can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the ALDH7A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so general concerns about symptoms, treatment, or medication side effects are best discussed with your doctor.
History
Doctors had recognized a rare form of seizures that improved with vitamin B6 as early as the 1950s, especially in newborns and infants. For many years, the biological cause remained unclear, even though the pattern was becoming more familiar in pediatric neurology. From these first observations, research expanded steadily. In 2006, researchers identified variants in the ALDH7A1 gene as a key cause of pyridoxine dependent epilepsy, a landmark step that connected the clinical picture to a specific inherited condition. This discovery helped replace older, less precise descriptions with a clearer genetic diagnosis. It also opened the way for more reliable family testing and earlier recognition in babies with otherwise unexplained seizures.